UNSPSC 51373417: Brompheniramine/codeine/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373417 Brompheniramine/codeine/phenylpropanolamine is a Commodity code that maps poorly to actual state and local procurement activity. Recent solicitations tagged with this code show no connection to the specific pharmaceutical combination the code names — instead, state and local buyers are procuring naloxone, safe drug deactivation systems, and generic multi-source pharmaceuticals through open competitive processes. The mismatch suggests either systematic miscoding by the issuing bodies or that the code is being used as a catchall for pharmaceutical procurement when more precise codes do not apply. State and local governments soliciting under this code include county health departments (Seminole County, Florida) and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, administered by the Minnesota Department of Administration). The scope spans acute pharmaceutical commodities for public health response, over-the-counter products for government facilities, and emergency medical supplies distributed through authorized pharmaceutical wholesalers.

Activity appears concentrated in Florida and Minnesota. Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026 and contracts effective July 1, 2026. Both solicitations required detailed product specification compliance, relationships with authorized wholesalers or distribution channels, and cGMP or equivalent certification. The code shows limited recent activity and poor semantic alignment with the commodity purchased; bid with caution and verify actual product scope before pursuing.